• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纯卵巢透明细胞癌、混合型和高级别浆液性腺癌病例的临床特征及转归

The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.

作者信息

Kucukgoz Gulec Umran, Paydas Semra, Guzel Ahmet Baris, Vardar Mehmet Ali, Khatib Ghanim, Gumurdulu Derya

机构信息

Department of Obstetrics and Gynecology, Faculty of Medicine, Cukurova University, 01330, Adana, Turkey,

出版信息

Arch Gynecol Obstet. 2015 Oct;292(4):923-9. doi: 10.1007/s00404-015-3699-9. Epub 2015 Apr 9.

DOI:10.1007/s00404-015-3699-9
PMID:25855053
Abstract

PURPOSE

This study aimed to compare the clinical characteristics and outcomes of the cases with pure ovarian clear cell adenocarcinoma (OCCC), mixed type (clear plus serous or clear plus endometrioid or serous plus clear plus endometrioid) ovarian adenocarcinoma (MOC) and high-grade serous ovarian adenocarcinoma (HGSOC).

METHODS

A retrospective comparison was conducted in 32 cases with pure OCCC, 23 cases with MOC and 28 cases with HGSOC followed between January 1999 and October 2011. Clinico-pathologic characteristics including histopathologic subtypes, age, stage, presence of ascites and/or peritoneal carcinomatosis, endometriosis and optimal cytoreduction, and also survival rates were compared in these three groups.

RESULTS

The cases with pure OCCC were younger than the cases with MOC and HGSOC (p = 0.004). The median pre-operative CA-125 level was lower in the pure OCCC than in MOC and HGSOC (p = 0.006) (p = 0.001, p = <0.001, respectively). Bilaterality and peritoneal carcinomatosis were more frequently seen in the HGSOC group (p = 0.001, p < 0.001, respectively). The majority of the cases (65 %) had stage I or II disease in the pure OCCC group, but most of the cases in the HGSOC group had advanced stage disease (p < 0.001). Endometriosis was found in 16 cases (16/55, 29 %) in the OCCC group. No significant difference was detected with regard to the median survival rate among three groups (p = 0.517), while the stage of disease was found to be the only important factor for survival (p = 0.002).

CONCLUSION

Pure OCCC, MOC and HGSOC represent distinct clinical characteristics. Clinical characteristics of MOC are more similar to those of HGSOC.

摘要

目的

本研究旨在比较单纯性卵巢透明细胞腺癌(OCCC)、混合型(透明细胞加浆液性或透明细胞加子宫内膜样或浆液性加透明细胞加子宫内膜样)卵巢腺癌(MOC)和高级别浆液性卵巢腺癌(HGSOC)的临床特征及预后。

方法

对1999年1月至2011年10月期间随访的32例单纯性OCCC、23例MOC和28例HGSOC患者进行回顾性比较。比较这三组患者的临床病理特征,包括组织病理学亚型、年龄、分期、腹水和/或腹膜种植转移、子宫内膜异位症及最佳肿瘤细胞减灭术情况,以及生存率。

结果

单纯性OCCC患者比MOC和HGSOC患者年轻(p = 0.004)。单纯性OCCC患者术前CA-125水平中位数低于MOC和HGSOC患者(p = 0.006)(分别为p = 0.001,p < 0.001)。双侧性和腹膜种植转移在HGSOC组更常见(分别为p = 0.001,p < 0.001)。单纯性OCCC组大多数病例(65%)为Ⅰ期或Ⅱ期疾病,而HGSOC组大多数病例为晚期疾病(p < 0.001)。OCCC组有16例(16/55,29%)发现子宫内膜异位症。三组患者的中位生存率无显著差异(p = 0.517),而疾病分期是生存的唯一重要因素(p = 0.002)。

结论

单纯性OCCC、MOC和HGSOC具有不同的临床特征。MOC的临床特征与HGSOC更相似。

相似文献

1
The clinical characteristics and outcomes of cases with pure ovarian clear cell, mixed type and high-grade serous adenocarcinoma.纯卵巢透明细胞癌、混合型和高级别浆液性腺癌病例的临床特征及转归
Arch Gynecol Obstet. 2015 Oct;292(4):923-9. doi: 10.1007/s00404-015-3699-9. Epub 2015 Apr 9.
2
Associations between residual disease and survival in epithelial ovarian cancer by histologic type.不同组织学类型上皮性卵巢癌中残余病灶与生存的相关性。
Gynecol Oncol. 2017 Nov;147(2):250-256. doi: 10.1016/j.ygyno.2017.08.003. Epub 2017 Aug 16.
3
Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?子宫内膜异位症的存在与纯卵巢透明细胞癌的生存获益相关吗?
Arch Gynecol Obstet. 2018 Apr;297(4):1005-1013. doi: 10.1007/s00404-018-4651-6. Epub 2018 Jan 30.
4
Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.晚期透明细胞上皮性卵巢癌:希腊肿瘤协作组的经验
Gynecol Oncol. 2006 Aug;102(2):285-91. doi: 10.1016/j.ygyno.2005.12.038. Epub 2006 Mar 3.
5
An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.铂类疗法治疗的透明细胞癌与浆液性癌卵巢癌患者的无进展生存期和总生存期评估:NRG肿瘤学/妇科肿瘤学组经验
Gynecol Oncol. 2017 Nov;147(2):243-249. doi: 10.1016/j.ygyno.2017.08.004. Epub 2017 Aug 12.
6
Evolving population-based statistics for rare epithelial ovarian cancers.不断变化的基于人群的罕见上皮性卵巢癌统计数据。
Gynecol Oncol. 2020 Apr;157(1):3-11. doi: 10.1016/j.ygyno.2019.11.122. Epub 2020 Jan 15.
7
Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.早期低级别卵巢透明细胞癌与高级别组织学亚型相比:两个肿瘤中心的结局探索性分析。
Gynecol Oncol. 2021 Jan;160(1):64-70. doi: 10.1016/j.ygyno.2020.10.014. Epub 2020 Oct 17.
8
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.在铂类药物时代,Ⅰ期子宫内膜样或透明细胞卵巢癌患者的辅助化疗:一项监测、流行病学和最终结果的队列研究,2000-2013 年。
Ann Oncol. 2017 Dec 1;28(12):2985-2993. doi: 10.1093/annonc/mdx525.
9
Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.高危早期上皮性卵巢癌的预后因素:一项妇科肿瘤学组的研究
Cancer. 2008 May 15;112(10):2202-10. doi: 10.1002/cncr.23390.
10
Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology-A Comparative Study.浆液性和透明细胞组织学类型的原发性卵巢腺癌的人口统计学、临床及预后因素——一项比较研究
Int J Gynecol Cancer. 2016 Jan;26(1):82-90. doi: 10.1097/IGC.0000000000000585.

引用本文的文献

1
Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.卵巢混合细胞性腺癌患者预后列线图模型的建立与鉴定。
J Ovarian Res. 2021 Oct 21;14(1):137. doi: 10.1186/s13048-021-00896-9.
2
SR-B1 and CD10 combined immunoprofile for differential diagnosis of metastatic clear cell renal cell carcinoma and clear cell carcinoma of the ovary.SR-B1 和 CD10 联合免疫组化标记用于鉴别诊断转移性透明细胞肾细胞癌和卵巢透明细胞癌。
J Mol Histol. 2021 Jun;52(3):539-544. doi: 10.1007/s10735-021-09963-3. Epub 2021 Feb 19.
3
Clear cell carcinoma of the ovary: Clinicopathologic features and outcomes in a Chinese cohort.
卵巢透明细胞癌:中国队列中的临床病理特征及预后
Medicine (Baltimore). 2018 May;97(21):e10881. doi: 10.1097/MD.0000000000010881.